Clinical Trials Browser

Phase 3 × Differentiated Thyroid Cancer × apatinib × Clear all

NCT03048877 2023-04-12

Efficacy of Apatinib in Radioactive Iodine-refractory Differentiated Thyroid Cancer

Phase 3 Unknown

EndocrineHead & Neck

Differentiated Thyroid Cancer